Most people on Ozempic lose between 5% and 15% of their body weight, with results varying widely depending on dose, diet, exercise, and individual biology. For someone who weighs 220 pounds, that translates to roughly 11 to 33 pounds. Combined with consistent lifestyle changes, some clinical studies show losses of 20% to 26% of body weight over six months to a year, though those higher numbers are more commonly seen with Wegovy, the higher-dose version of the same drug.
What the Numbers Actually Look Like
Ozempic contains semaglutide, the same active ingredient as Wegovy, but it’s FDA-approved for type 2 diabetes rather than weight loss. Its maximum dose is 2.0 mg per week, compared to Wegovy’s 2.4 mg. That dose difference matters for results.
In the SUSTAIN FORTE trial, which compared Ozempic’s 1 mg and 2 mg doses over 40 weeks in people with type 2 diabetes, average weight loss ranged from about 7 to 14 pounds. That’s a more modest number than many people expect, partly because this trial studied people with diabetes (who tend to lose less weight on these drugs than people without diabetes) and partly because Ozempic’s top dose is lower than Wegovy’s.
When semaglutide is dosed at 2.4 mg (the Wegovy dose), clinical trials show an average weight loss of about 14% of body weight at 72 weeks. Many doctors prescribe Ozempic off-label for weight loss, and your results will likely fall somewhere between the diabetes trial numbers and the Wegovy trial numbers, depending on your dose and starting weight.
Not Everyone Responds the Same Way
One of the most important things the clinical data reveals is how much individual results vary. In the large STEP trials of semaglutide 2.4 mg, roughly 32% to 40% of participants were “super responders” who lost more than 20% of their body weight. At the other end, 10% to 17% were “non-responders” who lost less than 5%. The majority fell somewhere in between.
There’s no reliable way to predict which group you’ll fall into before starting. Genetics, metabolic factors, how well you tolerate the medication, and how much your appetite actually shifts all play a role. If you’ve been on Ozempic for three to four months and haven’t seen meaningful changes on the scale, that’s a reasonable point to reassess with your prescriber whether the dose needs adjusting or a different medication might work better.
A Realistic Month-by-Month Timeline
Ozempic is started at a low dose and gradually increased every four weeks to reduce side effects. This slow ramp-up means the first month or two are not when dramatic weight loss happens. Here’s what to expect:
- Month 1: You’ll likely notice reduced appetite and better portion control before you see the scale move much. You’re on the lowest dose, and your body is adjusting.
- Months 2 to 3: As the dose increases, noticeable weight loss typically begins. Most people start seeing meaningful changes around the three- to four-month mark.
- Months 4 to 6: Weight loss continues at a steady pace, particularly once you reach your maintenance dose. This is when results become most visible.
- Months 6 to 12: The rate of loss gradually slows as your body approaches a new set point. The best overall results are typically achieved somewhere in this window.
Ozempic vs. Wegovy vs. Tirzepatide
Since many people considering Ozempic are also weighing other options, the comparisons are worth knowing. Wegovy is the same molecule at a higher maximum dose (2.4 mg vs. 2.0 mg), and it’s the only semaglutide product actually approved for weight management. If weight loss is your primary goal, Wegovy is technically the more appropriate prescription, and research supports slightly better results at the higher dose.
Tirzepatide, sold as Mounjaro (for diabetes) and Zepbound (for weight loss), works on two gut hormone pathways instead of one. In a head-to-head trial of 751 people with obesity, tirzepatide produced an average 20% weight loss at 72 weeks compared to 14% for semaglutide, both at maximum doses. That six-percentage-point gap is significant. For someone starting at 250 pounds, it’s the difference between losing about 35 pounds and losing 50.
Side Effects That Affect Your Results
The most common side effects are nausea, vomiting, diarrhea, and constipation, especially during the first few weeks at each new dose level. In clinical trials, about 3% to 4% of people on Ozempic discontinued the medication because of gastrointestinal side effects, compared to less than 1% on placebo. That’s a relatively low dropout rate, meaning most people can tolerate the drug well enough to stay on it.
That said, the people who struggle most with nausea sometimes can’t increase to higher doses, which limits their weight loss. Eating smaller meals, avoiding high-fat foods, and staying hydrated can help manage symptoms during the dose escalation period. If side effects are severe enough to keep you on a lower dose long-term, your total weight loss will likely be on the lower end of the range.
What Happens If You Stop
This is the part most people don’t want to hear, but it’s critical for setting expectations. A 2026 meta-analysis published in The Lancet modeled weight regain after stopping GLP-1 drugs and found that people regained about 60% of the weight they’d lost within one year of stopping. The regain eventually plateaus at around 75% of the lost weight.
So if you lost 30 pounds on Ozempic and then stopped, you’d likely regain about 18 pounds within a year and potentially 22 to 23 pounds over the longer term. This doesn’t mean the medication “didn’t work.” It means obesity is a chronic condition, and semaglutide manages it rather than curing it, similar to how blood pressure medication controls hypertension without permanently fixing it. Most people who achieve significant results will need to stay on the medication long-term, taper to a lower maintenance dose, or adopt substantial lifestyle changes to preserve their progress.